Prothera Biosciences
August 13, 2015
Roche Pharma Research and Early Development, a division of Roche Pharmaceuticals, has developed a new mobile app to measure Parkinson's disease symptoms. The app was developed in partnership with Max Little, a British mathametician at the head of the Parkinson's Voice Initiative, and it will actually be used in a drug development trial with Prothena Biosciences.
“The app is being used in a Phase...
Editor's Pick
March 18, 2016
February 26, 2016
February 26, 2016
February 23, 2016
March 18, 2016
March 08, 2016
